An Open-Label, Observational Study of the Effects of Anti-TNF Therapy on Peripheral Blood and Synovial Biomarkers in Patients with Active Rheumatoid Arthritis.

At a glance
Trial Overview
Trial Details
Interventions
Trial Centres
- Centres
Trial History
References

Trial Profile

An Open-Label, Observational Study of the Effects of Anti-TNF Therapy on Peripheral Blood and Synovial Biomarkers in Patients with Active Rheumatoid Arthritis.

Status: Discontinued

Phase of Trial: Phase IV

Latest Information Update: 24 Sep 2019

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Etanercept (Primary) ; Adalimumab
Indications Rheumatoid arthritis
Focus Biomarker; Therapeutic Use
Sponsors Roche

Most Recent Events

24 Sep 2019 Status changed from recruiting to discontinued.
29 Jul 2019 This trial is completed in United Kingdom according to Eudra
25 Jul 2011 This trial is recruiting in United Kingdom and has discontinued in Sweden.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com